NCT06423729View on ClinicalTrials.gov

Effect of Nicorandil in Type 2 Diabetic Obese Patients

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Nicorandil 10 MG

Patients will receive oral Nicorandil 10 MG twice daily in addition to 2nd generation sulfonylureas , for 3 months.

Trial Locations (1)

31511

RECRUITING

Faculty of Pharmacy, Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER